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Abstract
Introduction: Social distancing has been utilized during the COVID-19 pandemic to reduce the 
spread of SARS-CoV-2, which is also expected to reduce the spread of common respiratory 
viruses. 
Methods: This retrospective, descriptive study assessed the rate of positivity of common res-
piratory viruses from commercially available respiratory pathogen panel, across a five-hospital 
health-system, during four-week periods within March to April of 2019 and 2020.
Results: During the four-week period in 2019, the percent positivity of common respiratory 
viruses from week one to week four decreased from 6 to 32% among the four included viruses. 
In the comparator period in 2020, a decrease ranging from 74 to 100% was observed from week 
one to week four.
Conclusions: These data indicate that the social distancing efforts implemented in Louisville, 
Kentucky, may be associated with a decrease in incidence of common respiratory viruses.  This 
decrease in positivity of common respiratory viruses may serve as a surrogate marker for the 
effect of social distancing on the transmission of SARS-CoV-2.  
Introduction
Social distancing has become a key intervention in preventing the spread of SARS-CoV-2 
during the COVID-19 pandemic. [1,2] Throughout March and April of 2020 several in-
terventions aimed at reducing the spread of SARS-CoV-2 have been implemented by na-
tional, state, and local governments in a stepwise manner.  In Louisville, Kentucky, these 
include limits on public gatherings (3/11), closure of schools (3/12), closure of non-es-
sential businesses (3/23), and more. [3-5]  We hypothesize that these interventions, 
which were intended to address the current pandemic, would have a significant impact 
on the droplet transmission of common respiratory virus including influenza, respira-
tory syncytial virus (RSV),  rhinovirus, and common coronaviruses (HKU1, NL63, 229E, 
and OC43). [6] The objective of this study is to assess the effect of social distancing on 
the incidence of common respiratory viruses as a surrogate marker for the reduction in 
transmission of SARS-CoV-2.    
Methods
This was a retrospective, descriptive study examining the incidence of selected commu-
nity respiratory viruses (influenza, RSV, rhinovirus, and common coronaviruses) detect-
ed by a multiplex molecular respiratory viral panel between 3/10/2019 to 4/6/2019 and 
3/8/2020 to 4/4/2020 within the Norton Healthcare health-system.  Norton Healthcare 
consists of five hospitals with over 1800 licensed beds, immediate care centers, and am-
bulatory medical practices throughout Louisville, Kentucky.   A commercially available 
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respiratory pathogen panel (RPP) performed in the system’s centralized microbiology laboratory is utilized to identify 
the previously listed common respiratory viruses.  This panel is available year-round and can be ordered by any physi-
cian or advanced practice provider for work-up of suspected respiratory illnesses in inpatient and outpatient settings. 
During the study period all RPP results were recorded and a weekly percent positivity rate for each of the included 
common respiratory viruses was calculated and plotted on a line graph for each week. 
Results
An average of 264 RPPs per week was obtained during the study period in 2019 and an average of 388 per week was 
obtained in 2020.  There was no consistent trend in the incidence of common respiratory viruses during the four-week 
period in 2019 (Figure 1).  In contrast, incidence of all common respiratory viruses showed a sharp decline over the 
same period in 2020 (Figure 2).  The percentage decrease for common coronaviruses from weeks one to four in 2019 
was 27% compared to 90% in 2020.  The respective decreases were 32% in 2019 and 74% in 2020 for rhinovirus, 6% in 
2019 and 100% in 2020 for influenza, and 25% in 2019 and 100% in 2020 for RSV (Figure 3 and Figure 4).
 
CoV=Coronaviruses (HKU1, NL63, 229E, and OC43); RSV=respiratory syncytial virus
Figure 1.  Incidence of Common Respiratory Viruses in a Four Week Period in 2019 
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CoV=Coronaviruses (HKU1, NL63, 229E, and OC43); RSV=respiratory syncytial virus
Figure 2.  Incidence of Common Respiratory Viruses in a Four Week Period in 2020
CoV=Coronaviruses (HKU1, NL63, 229E, and OC43); RSV=respiratory syncytial virus
Figure 3.  Percentage Positivity Relative to Baseline in the Four Week Period from 2019
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Discussion
These data display a significant decrease in the incidence of common respiratory virus detected by the RPP starting on 
the week of 3/22/2020. While there were decreases noted from week to week among the different common respiratory 
viruses in 2019, there was no consistent decline across all noted common respiratory viruses as seen in 2020.   Further-
more, the percentage decreases across the four-week period observed in 2020 were a significantly greater magnitude, 
ranging from 74% to 100%, than those observed in 2019 which ranged from 6% to 32%.   
The observed decrease in common respiratory viruses in 2020 coincided with the closure of all non-essential retail 
businesses in Kentucky, which was the most significant step to date in social distancing.  The noted decline in incidence 
of common respiratory viruses in the third and fourth weeks of these data suggest that the implemented social distanc-
ing efforts had an impact on common respiratory virus transmission.  These data also emphasize the importance of 
avoiding contact with others when ill in pandemic and non-pandemic scenarios.  
While these data highlight the effect of social distancing on common respiratory viruses, it is expected that efforts also 
led to a reduction in SARS-COV-2 transmission as intended.  As of 4/20/2020, Kentucky had fewer reported COVID-19 
cases than all but one (West Virginia) of the seven states it borders. [7] Without the effect of the social distancing efforts 
enacted swiftly in Kentucky, it is likely that the case burden would be significantly higher and may have resulted in the 
overwhelming the healthcare system.  
In conclusion, the rate of positivity on the RPP of a select group of common respiratory viruses declined simultaneous-
ly with the implementation of strict social distancing guidance in Kentucky.  The decline occurred more precipitously 
in 2020 than it did over the same time period in 2019, and was demonstrable in all of the viruses studied, suggesting 
that the demonstrated decline was likely not due to an expected end to the respiratory virus season, but was instead a 
result of factors unique to 2020.  These data indicate the potential effectiveness of social distancing in reducing com-
mon respiratory virus incidence and thus may serve as a surrogate marker for efficacy in reducing the transmission of 
SARS-CoV-2 as well.

















































































CoV=Coronaviruses (HKU1, NL63, 229E, and OC43); RSV=respiratory syncytial virus
Figure 4.  Percentage Positivity Relative to Baseline in the Four Week Period from 2020
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Appendix: CERID COVID-19 Study Group
Available upon request.
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